Online Program Home
My Program

Abstract Details

Activity Number: 476 - SPEED: Clinical Trial Design, Longitudinal Analysis, and Other Topics in Biopharmaceutical Statistics
Type: Contributed
Date/Time: Wednesday, August 1, 2018 : 8:30 AM to 10:20 AM
Sponsor: Biopharmaceutical Section
Abstract #329901 Presentation
Title: A Stagewise Prognostic Control Predictive Approach (SPCPA) for Subgroup Identification and Its Application in a Phase II Study
Author(s): Wanying Li* and Wangshu Zhang and Lovely Goyal and Yuanyuan Xiao
Companies: Gilead Sciences and Gilead Sciences and Gilead Sciences and Gilead Sciences
Keywords: subgroup identification; machine learning; predictive factor; prognostic factor; biomarker

The statistical problems underlying subgroup identification in clinical studies are to identify the predictors related to the treatment outcome and to determine an algorithm that defines the subgroup of interest based on those predictors. While there are recent advancements in subgroup identification using machine learning techniques, many of them focus on identifying the factors that demonstrate differential predictive values between treatment groups (i.e. predictive factors). However, prognostic factors, which show similar predictive values across treatment groups, can sometimes be of interest. Incorporating them into the subgroup identification procedures potentially can not only improve model performance, but also provide results with more solid clinical and biological interpretations. This paper proposes a stage-wise approach that unifies prognostic and predictive factor identification and subgroup determination with controlled type I error, and presents an example of its application to a phase II study.

Authors who are presenting talks have a * after their name.

Back to the full JSM 2018 program